The risk of mortality in patients with COVID-19 with pre-diagnosis use of NSAIDs: a meta-analysis

The notion that the use of non-steroidal anti-inflammatory drugs (NSAIDs) may lead to adverse outcomes upon acquisition of coronavirus disease 2019 (COVID-19) should be discredited with a review of the real-life evidence. We aimed to perform a meta-analysis to summarize the risk of mortality with th...

Descripción completa

Detalles Bibliográficos
Autores principales: Kow, Chia Siang, Hasan, Syed Shahzad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059110/
https://www.ncbi.nlm.nih.gov/pubmed/33881684
http://dx.doi.org/10.1007/s10787-021-00810-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059110/
https://www.ncbi.nlm.nih.gov/pubmed/33881684
http://dx.doi.org/10.1007/s10787-021-00810-1

Ejemplares similares